CD19 and chronic myelogenous leukemia, BCR-ABL1 positive: Figure 2(c) shows that while the majority (>98%) of human CML-derived K562 cells were negative for CD19 and CD138, human ALL-derived REH cells were shown to be positive for both antigens (>98% CD19; >70% CD138).